Navigation Links
Health Strategies Group Forecasts Emerging Trends in Future Sales Force Models at the SPBT 2009 Conference
Date:5/20/2009

LAMBERTVILLE, N.J., May 20 /PRNewswire/ -- Health Strategies Group, a leading provider of market intelligence to the pharmaceutical and biotechnology industries, analyzed trends shaping future sales force models and outlined actionable training strategies to address these new models at the 38th Annual Society of Pharmaceutical and Biotech Trainers (SPBT) Conference, held May 11-14 in Chicago.

In an address titled "Sales Force of the Future," consultants Denise Woltemath and Manny Gaspar assessed four potential new sales models that may occur in the rapidly changing pharmaceutical and biotechnology environment. The team examined selling scenarios where (1) specialty representatives become the dominant sales force type, (2) a split develops between clinical representatives and service representatives, (3) the district manager evolves into a market manager and (4) targeted deployment becomes the standard practice, i.e. companies segment and target physicians according to their information delivery preferences.

The Health Strategies Group consultants shared insights with workshop participants on how to identify emerging sales force trends within their own organizations and discussed possible training plans and requirements for each of the four sales models presented.

"We were pleased to be invited to share and discuss our training ideas and analysis with the industry leaders at the SPBT annual conference," said Gaspar. "We received a lot of positive feedback from our workshop participants, many commented they had learned several methods they can implement now to navigate the changing pharmaceutical environment. We value our longstanding relationship with SPBT and are always grateful for the opportunity to collaborate with their members."

For a summary of Health Strategies Group's SPBT presentation, "Sales Force of the Future," contact info@healthstrategies.com.

About the Speakers

Denise Woltemath is a senior consultant with Health Strategies Group, leading the Specialty Sales Opportunity Assessment Service for specialty and biotechnology clients. She has more than 20 years of healthcare experience and has held leadership roles in pharmaceutical sales, managed care, medical devices and hospital settings. Woltemath's achievements include development of a training initiative that doubled the length of sales calls, management of a systematic approach to extending the impact of promotional education programs, and creation of a company-wide framework for opinion leader development.

Manny Gaspar is a consultant with Health Strategies Group and is responsible for syndicated and client private projects within the company's Strategic Selling Outlook practice. His professional experience spans the healthcare marketing spectrum, including work in analytics, sales, and product management in both the pharmaceutical and medical device industries.

About Health Strategies Group

Health Strategies Group has been providing market intelligence to pharmaceutical and biotechnology professionals since 1992, transforming research findings into practical insights and strategic recommendations to help organizations make the best business decisions. The company has long-standing relationships with 90 percent of the nation's leading pharmaceutical and biotechnology companies.

Health Strategies Group services include syndicated research reports in different practice areas, proprietary intelligence projects on request, and direct, continuous access to a team of research directors and practice leaders who are experienced veterans of the pharmaceutical industry and active thought leaders in their areas of expertise. The company also creates a custom webpage for each client that provides ready access to all pertinent publications and research summaries.

Organizations use Health Strategies Group to assess marketplace trends and future scenarios, support business planning, formulate successful segmentation strategies, guide the design of training curricula, educate colleagues, benchmark staff performance, and develop more profitable contracting strategies.

For additional information on Health Strategies Group, contact Karen Vandeven, director of marketing and communications, at (609) 397-5282 or kvandeven@healthstrategies.com. Health Strategies Group is headquartered in Lambertville, N.J., with regional offices in Redwood City, Carlsbad and Irvine, Calif. Visit the company's Web site at www.HealthStrategies.com.

    CONTACT: Bridget Calafell Wood               Cynthia Amorese
             (212) 286-2424                      (908) 665-8072
             Email: bcalafell@julielaitin.com    Email: camorese@comcast.net


'/>"/>
SOURCE Health Strategies Group
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
3. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
4. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
5. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
6. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
7. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
8. Apria Healthcare Chooses Masimo SET Pulse Oximetry for Use in the Companys Home Health Care Business
9. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
10. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
11. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case report published today in ... patient who developed lymphedema after being treated for breast cancer benefitted from an injection ... for dealing with this debilitating, frequent side effect of cancer treatment. , ...
(Date:6/23/2016)... YORK , June 23, 2016 ... trading session at 4,833.32, down 0.22%; the Dow Jones Industrial ... S&P 500 closed at 2,085.45, down 0.17%. Stock-Callers.com has initiated ... INFI ), Nektar Therapeutics (NASDAQ: NKTR ), ... Therapeutics Inc. (NASDAQ: BIND ). Learn more about ...
Breaking Biology Technology:
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
(Date:5/12/2016)... May 12, 2016 WearablesResearch.com , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
Breaking Biology News(10 mins):